Alternatives to Elicit
Elicit is an Artificial Intelligence tool: AI-powered research assistant for scientific literature review and data extraction. Here are the 51 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Artificial Intelligence companies to Elicit
PredocNot ratedPreDoC is a distributor of drip dispersal septic systems in Pennsylvania. We also provide septic services to residential, commercial, and municipal clients.
Consensus3.0 out of 5 (1)An AI-powered search engine that accelerates academic research by extracting and synthesizing findings from over 250 million peer-reviewed papers.
JenniNot ratedAI workspace for researchers to read, write, and organize research.
- PapertoolNot rated
Read any research paper, plainly.
Iris.aiNot ratedAI knowledge foundation for regulated enterprises, turning complex data into AI you can trust.
Semantic ScholarNot ratedAI-powered research tool that helps scientists and researchers discover and understand scientific literature.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
OwkinNot ratedAI company using federated learning to solve biological complexity and accelerate drug discovery.
- ASAstromechNot rated
AI-driven predictive modeling company focused on biology and life sciences.
Unreasonable LabsNot ratedBuilding foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.
PickmybrainNot ratedAI-powered Digital Brains for professionals and public figures.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Showing the next 20 closest matches. See the rest on the Elicit profile.
Sponsored rows are paid and labelled. Advertise on this page

